Detalles de la búsqueda
1.
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities.
Blood;
141(5): 503-518, 2023 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35981563
2.
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients.
Br J Haematol;
202(5): 953-959, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357817
3.
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
Br J Haematol;
203(4): 637-650, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700538
4.
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
N Engl J Med;
383(17): 1613-1623, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085860
5.
Sialylation regulates migration in chronic lymphocytic leukemia.
Haematologica;
108(7): 1851-1860, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779594
6.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica;
108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
7.
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Hematol Oncol;
41(1): 50-60, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251440
8.
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
Haematologica;
107(4): 868-876, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092056
9.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica;
106(1): 39-45, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879328
10.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica;
106(6): 1559-1568, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467145
11.
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
Hematol Oncol;
39(5): 680-686, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402088
12.
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Am J Hematol;
96(3): 292-301, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284999
13.
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.
Br J Haematol;
188(2): 249-258, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385309
14.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol;
189(5): 853-859, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064595
15.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol;
38(5): 698-704, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816326
16.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Br J Cancer;
121(2): 150-156, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209327
17.
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Br J Haematol;
184(3): 392-396, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338509
18.
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Haematologica;
104(2): 312-318, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190342
19.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol;
37(4): 368-374, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325190
20.
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Br J Haematol;
181(5): 642-652, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675955